Epstein—Barr Virus Nuclear Antigen in a Non-Hodgkin's Lymphoma

References

• Ziegler J L, Andersson M, Klein G, et al. Detection of Epstein-Barr virus DNA in American Burkitt's lymphoma. Int I Cancer 1976; 17: 701–706
   PubMed Web of Science ®Google Scholar
• Henle G, Henle W. Immunofluorescence in cells derived from Burkitt's lymphoma. J Bact 1966; 91: 1248–1256
   PubMed Web of Science ®Google Scholar
• Andersson M, Klein G, Ziegler J L, et al. Association of Epstein-Barr viral genomes with American Burkitt's lymphoma. Nature (London) 1976; 260: 357–360
   PubMed Web of Science ®Google Scholar
• Huang D P, Ho H C, Henle W, et al. Demonstration of Epstein-Barr virus-associated nuclear antigen in nasopharyngeal carcinoma cells from fresh biopsies. Int J Cancer 1974; 14: 580–588
   PubMed Web of Science ®Google Scholar
• Wolf H, Zur Hausen H, Becker V, et al. Epstein-Barr genomes in epithelial nasopharyngeal carcinoma cells. Nature (New Biol) 1973; 224: 245–247
   Google Scholar
• Lemon S M, Hutt L M, Shaw J E, et al. Replication of EBV in epithelial cells during infectious mononucleosis. Nature (London) 1977; 268: 268–270
   PubMed Web of Science ®Google Scholar
• Chang R C, Lewis J P, Abildgaara C F. Presence of oropharyngeal secretors of leukocyte transforming agents among a human population. N Engl J Med 1973; 289: 1325–1329
   PubMed Web of Science ®Google Scholar
• Reedman B, Klein G. Cellular localization of an Epstein-Barr virus (EBV)-associated complement-fixing antigen in producer and non-producer lymphoblastoid cell lines. Int J Cancer 1973; 11: 499–520
   PubMed Web of Science ®Google Scholar
• Henle W, Henle G. Epstein-Barr virus-related serology in Hodgkin's disease. Natl Cancer Inst Monogr 1973; 36: 79
   PubMedGoogle Scholar
• Hesse J, Anderson E, Levine P H, et al. Antibodies to Epstein-Barr virus and cellular immunity in Hodgkin's disease and chronic lymphocytic leukemia. Int J Cancer 1973; 11: 237–243
   PubMed Web of Science ®Google Scholar
• Henle W, Ho W C, Kwan H C. Antibodies to Epstein-Barr virus-related antigens in nasopharyngeal carcinoma. Comparison of active cases and long term survivors. J Natl Cancer Inst 1973; 51: 361–369
   PubMed Web of Science ®Google Scholar
• Henle W, Ho H C, Henle G, et al. Nasopharyngeal carcinoma: Significance of changes in Epstein-Barr virus-related antibody patterns following therapy. Int J Cancer 1977; 20: 663–672
   PubMed Web of Science ®Google Scholar
• Henle G, Henle W, Klein G, et al. Antibodies to an early Epstein-Barr virus-induced antigen in Burkitt's lymphoma. J Natl Cancer Inst 1971; 46: 861–871
   PubMed Web of Science ®Google Scholar
• Henle W, Henle G, Zajac B, et al. Differential reactivity of human sera with EBV-induced “early antigens.”. Science 1970; 169: 188–190
   PubMed Web of Science ®Google Scholar
• Armstrong G, Longo D, Faggioni A, . Detection and isolation of Epstein-Barr virus in lymphocytes from patients with chronic lymphocytic leukemia (CLL). Role of Environment and Pathogenesis of Leukemia and lymphoma, Progress in Cancer Research and Therapy, I T Magrath, G T O'Conor, B Ramot, et al. Raven Press, New York, Vol. 27, in press
   Google Scholar
• Levitt M L, Barry W E, Helfrich M K, et al. Characterization of Epstein-Barr virus-carrying cell lines established from chronic lymphocytic leukemia. Cancer Res 1983; 43: 1195–1203
   PubMed Web of Science ®Google Scholar
• Lukes R J, Collins R D. Immunologic characterization of human malignant lymphomas. Cancer 1974; 34: 1488–1503
   PubMed Web of Science ®Google Scholar
• Rappaport H. Atlas of Tumor Pathology. Armed Forces Institute of Pathology, Washington, DC 1966, Sect. I, Fasc. 8
   Google Scholar
• Slovin S F, Vaughan J H, Carson D A. Changes in the expression of two Epstein-Barr virus-associated antigens, EBNA and RANA, during the cell cycle of transformed human B lymphoblasts. Int J Cancer 1980; 29: 9–12
   Google Scholar
• Slovin S F, Glassy M C, Dambaugh T, et al. Discordant expression of 2 Epstein-Barr virus-associated antigens, EBNA and RANA, in man-rodent somatic cell hybrids. J Immunol 1981; 127: 585–589
   PubMed Web of Science ®Google Scholar
• Purtilo D T, Paquin L, DeFloria D, et al. Immunodiagnosis and immunopathogenesis of the X-linked lymphoproliferative syndrome. Sem Hemat 1979; 16: 309–343
   PubMed Web of Science ®Google Scholar
• Crawford D H, Thomas J A, Janossy G, et al. Epstein-Barr virus nuclear antigen positive lymphoma after cyclosporin A treatment in patients with renal allografts. Lancet 1980; 1: 1355–1356
   PubMed Web of Science ®Google Scholar
• Robinson J E, Brown N, Andiman W, et al. Diffuse polyclonal B-cell lymphoma during primary infection with Epstein-Barr virus. N Engl J Med 1980; 302: 1293–1297
   PubMed Web of Science ®Google Scholar
• Thestrup-Pedersen K, Esmann V, Jensen J R, et al. Epstein—Barrvirus-induced lymphoproliferative disorder converting to fatal Burkitt-like lymphoma in a boy with interferon-inducible chromosomal defect. Lancet 1980; 2: 997–1001
   PubMed Web of Science ®Google Scholar
• Klein E, Klein G, Levine P H. Immunological control of human lymphoma: Discussion. Cancer Res 1976; 36: 724–727
   PubMed Web of Science ®Google Scholar
• Henle G, Henle W. The virus as the etiologic agent of infectious mononucleosis. The Epstein-Barr Virus, M A Epstein, B G Achong. Springer-Verlag, New York 1979; 312
   Google Scholar
• Levy Warnke R. R, Dorfman R F, et al. The monoclonality of human B-cell lymphomas. J Exp Med 1977; 145: 1014–1028
   PubMed Web of Science ®Google Scholar
• Friedman J M, Fialkow P J. Cell marker studies of human tumorigenesis. Transpl Rev 1976; 28: 2–86
   Google Scholar
• Kim H, Dorman R F. Morphological studies of 84 untreated patients subjected to laparotomy for the staging of non-Hodgkin's lymphomas. Cancer 1974; 33: 657–674
   PubMed Web of Science ®Google Scholar
• Potter M. Plasma cell neoplasia in single host: Mosaic of different protein-producing cell types. J Exp Med 1962; 115: 339–356
   PubMed Web of Science ®Google Scholar
• Bjerrum O J, Weeke B. Two M components (γGκ and γMΛ) indifferent cells of the same patient. Scand J Hematol 1968; 5: 215–234
   PubMedGoogle Scholar